Anthem Biosciences IPO IPO Subscription Status
The Anthem Biosciences IPO IPO closed on 16 July 2025 with an overall subscription of 67.42x based on shares applied. QIB demand came in at 192.80x, NII at 44.69x, and retail at 5.92x.
Allotment will be finalised on 17 July 2025. The stock is scheduled to list on NSE and BSE on 21 July 2025.
Issue Price
Rs 570.00
GMP Today
Rs 179.00 (+31.40%)
Overall Subscription
67.42x
Issue Size
₹3395.00 Cr
Allotment Date
17 Jul 2025
Listing Date
21 Jul 2025
Anthem Biosciences IPO IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 570.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 677.35 Cr | Rs 1,30,592.47 Cr | 192.80x |
| NII | Rs 508.01 Cr | Rs 22,703.49 Cr | 44.69x |
| sNII (Rs 2L to Rs 10L) | Rs 169.34 Cr | Rs 5,209.13 Cr | 30.76x |
| bNII (above Rs 10L) | Rs 338.68 Cr | Rs 17,494.36 Cr | 51.66x |
| Retail | Rs 1,185.36 Cr | Rs 7,022.82 Cr | 5.92x |
| Total | Rs 2,370.73 Cr | Rs 1,60,318.78 Cr | 67.62x |
Anthem Biosciences IPO IPO Subscription by Shares
Category-wise subscription based on shares bid. Application-wise bid counts are not available for this IPO yet.
| Category | Shares Offered | Shares Bid | Subscription |
|---|---|---|---|
| QIB | 1,18,83,334 | 2,29,10,95,976 | 192.80x |
| NII | 89,12,500 | 39,83,06,792 | 44.69x |
| sNII (Rs 2L to Rs 10L) | 29,70,833 | 9,13,88,258 | 30.76x |
| bNII (above Rs 10L) | 59,41,667 | 30,69,18,534 | 51.66x |
| Retail | 2,07,95,833 | 12,32,07,422 | 5.92x |
| Total | 4,15,91,667 | 2,81,26,10,190 | 67.62x |
What Do These Subscription Numbers Mean?
A subscription of 67.42x by shares means the IPO received bids for 67 times the shares reserved. Allotment odds depend on application count in each category, not share volume.
Here is what each category number tells you:
QIB at 192.80x by shares: This is the strongest signal on the page. QIBs are institutional investors, mutual funds, foreign institutions, and banks. When they subscribe at 192.80x, it reflects serious institutional conviction.
NII at 44.69x by shares: NII includes high net worth individuals applying above Rs 2 lakh. Proportional allotment uses application subscription.
Retail at 5.92x by shares: Allotment is by lottery, but application-wise data is needed for accurate 1-in-X odds. Share oversubscription often overstates how hard allotment is.
Anthem Biosciences IPO IPO Allotment Chances
Allotment odds below use application subscription (number of bids received), not share or amount subscribed.
Retail
- •Share subscription: 5.92x (application-wise data pending).
- •Allotment odds will be updated once application subscription is synced.
SHNI (Rs 2 lakh to Rs 10 lakh)
- •Share subscription: 30.76x (application-wise data pending).
- •Allotment odds will be updated once application subscription is synced.
BHNI (above Rs 10 lakh)
- •Share subscription: 51.66x (application-wise data pending).
- •Allotment odds will be updated once application subscription is synced.
Check the Anthem Biosciences IPO IPO Allotment Status page from 17 July 2025 for your allotment result.
Anthem Biosciences IPO IPO GMP After Subscription
GMP for Anthem Biosciences IPO stands at Rs 179.00 today, giving an estimated listing price of Rs 749.00 per share.
A subscription of 67.42x combined with a GMP of 31.40% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.
Track live GMP on the Anthem Biosciences IPO IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.
Anthem Biosciences IPO IPO Day-wise Subscription
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 14 Jul 2025 | 0.39x | 1.64x | 0.62x | 0.77x |
| Day 2 - 15 Jul 2025 | 0.62x | 10.26x | 2.21x | 3.48x |
| Day 3 - 16 Jul 2025 | 192.80x | 44.69x | 5.92x | 67.39x |
Anthem Biosciences IPO IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 14 July 2025 |
| IPO Close Date | 16 July 2025 |
| Allotment Date | 17 July 2025 |
| Refund Initiation | 18 July 2025 |
| Share Credit to Demat | 18 July 2025 |
| Listing Date | 21 July 2025 |
| Minimum Investment | Rs 14,820.00 |
| Lot Size | 26 shares |
About Anthem Biosciences IPO
Anthem Biosciences is a technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) for drug discovery, development and manufacturing. It offers comprehensive CRDMO services across the New Chemical Entity (NCE) and New Biological Entity (NBE) lifecycles. The company also manufactures and sells Active Pharmaceutical Ingredients (APIs), including probiotics, enzymes, peptides, nutritional actives, vitamin analogues and biosimilars.
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors
High net worth individuals applying above Rs 2 lakh. Divided into bNII (above Rs 10 lakh) and sNII (Rs 2 lakh to Rs 10 lakh). NII allotment is proportional.
Retail - Retail Individual Investors
Investors applying up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Minimum one lot per successful applicant.
Anthem Biosciences IPO IPO GMP Today
Live GMP, listing price estimate, and listing gain
Anthem Biosciences IPO IPO Allotment Status
Check allotment result on allotment date
Anthem Biosciences IPO IPO Details
Financials, peers, strengths, and review
All IPO Subscription Status
Subscription for all active IPOs
Anthem Biosciences IPO IPO Subscription FAQs
What is the current subscription status of Anthem Biosciences IPO?
Anthem Biosciences IPO IPO closed on 16 July 2025 with an overall subscription of 67.42x by shares. QIB subscribed 192.80x by shares, NII 44.69x by shares, and Retail 5.92x by shares.
What are the allotment chances for retail investors?
Share subscription was 5.92x. Application-wise data is needed for accurate lottery odds. Allotment is based on applications, not shares.
When will Anthem Biosciences IPO allotment be finalised?
Allotment will be finalised on 17 July 2025. You can check your allotment status on the Anthem Biosciences IPO IPO Allotment Status page from that date.
What happens after subscription closes?
After the subscription closes, the registrar processes all applications and finalises allotment on 17 July 2025. Refunds for unsuccessful applications are typically initiated before listing. Shares are credited to demat accounts before the listing date on 21 July 2025.
Can I apply after subscription closes?
No. The subscription window closed on 16 July 2025. All applications must be submitted during the open period. Late applications are rejected automatically.
What is the difference between QIB, NII, and Retail subscription?
QIB includes institutional investors such as mutual funds, FIIs, and banks. NII includes high net worth individuals applying above Rs 2 lakh. Retail includes individual investors applying up to Rs 2 lakh. Each category has separate reservation and different allotment rules.
How does subscription affect allotment chances?
Allotment odds depend on application subscription in each category, not share volume. In retail, lottery odds are roughly 1 in X where X is the application subscription multiple. SHNI and BHNI use proportional allotment based on application count. At 67.42x overall share subscription, competition is very high. Check application-wise figures for your category.
What is the issue size and lot size for Anthem Biosciences IPO?
Issue size is ₹3395.00 Cr. Lot size is 26 shares. Minimum investment at the issue price of Rs 570.00 is Rs 14,820.00 per lot.
For allotment results from 17 July 2025, visit the Anthem Biosciences IPO IPO Allotment Status page. For listing day updates on 21 July 2025, download the IPOwiz App.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. Subscription data verified before publish.